TNFA

TNF Pharmaceuticals, Inc. Common Stock

34 hedge funds and large institutions have $9.94M invested in TNF Pharmaceuticals, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
34
Holders Change
+7
Holders Change %
+25.93%
% of All Funds
0.59%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
11
Increased
4
Reduced
7
Closed
4
Calls
$383K
Puts
$231K
Net Calls
+$152K
Net Calls Change
+$144K
Name Holding Trade Value Shares
Change
Shares
Change %
Millennium Management
26
Millennium Management
New York
$37K +$37K +5 New
Bank of New York Mellon
27
Bank of New York Mellon
New York
$29K
Renaissance Technologies
28
Renaissance Technologies
New York
$27K +$27K +3 New
Simplex Trading
29
Simplex Trading
Illinois
$11K -$22K -2 -67%
AA
30
Ancora Advisors
Ohio
$7K
Royal Bank of Canada
31
Royal Bank of Canada
Ontario, Canada
$6K +$6K +1 New
Group One Trading
32
Group One Trading
Illinois
$5K
SSB
33
Sandy Spring Bank
Maryland
$5K
Osaic Holdings
34
Osaic Holdings
Arizona
$5K +$5K +1 New
Wells Fargo
35
Wells Fargo
California
$4K -$2K
IA
36
IFP Advisors
Florida
$4K
HBW
37
Hazlett, Burt & Watson
West Virginia
$1K
SJIM
38
St. Johns Investment Management
Florida
$1K
GWM
39
Geneos Wealth Management
Colorado
$1K -$1K
LFA
40
Level Financial Advisors
New York
$1K
NFSG
41
Newbridge Financial Services Group
Florida
$1K
TWC
42
TD Waterhouse Canada
Ontario, Canada
$117 -$81
IC
43
Ikarian Capital
Texas
-$176K -27 Closed
HF
44
HRT Financial
New York
-$39K -6 Closed
VF
45
Virtu Financial
New York
-$35K -5 Closed
SWM
46
SeaCrest Wealth Management
New York
-$15K -2 Closed
PFGIA
47
Patriot Financial Group Insurance Agency
Massachusetts
-$1K
Barclays
48
Barclays
United Kingdom
-$2K
TRCT
49
Tower Research Capital (TRC)
New York
-$2K
UBS Group
50
UBS Group
Switzerland
-$2K